|
US5260203A
(en)
|
1986-09-02 |
1993-11-09 |
Enzon, Inc. |
Single polypeptide chain binding molecules
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
US5091513A
(en)
|
1987-05-21 |
1992-02-25 |
Creative Biomolecules, Inc. |
Biosynthetic antibody binding sites
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
IL162181A
(en)
|
1988-12-28 |
2006-04-10 |
Pdl Biopharma Inc |
A method of producing humanized immunoglubulin, and polynucleotides encoding the same
|
|
US5183884A
(en)
|
1989-12-01 |
1993-02-02 |
United States Of America |
Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor
|
|
US5658920A
(en)
|
1991-01-16 |
1997-08-19 |
Daiichi Pharmaceutical Co., Ltd. |
Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound
|
|
JP3008226B2
(ja)
|
1991-01-16 |
2000-02-14 |
第一製薬株式会社 |
六環性化合物
|
|
EP0590058B1
(en)
|
1991-06-14 |
2003-11-26 |
Genentech, Inc. |
HUMANIZED Heregulin ANTIBODy
|
|
JP3359955B2
(ja)
|
1992-07-16 |
2002-12-24 |
第一製薬株式会社 |
抗腫瘍剤
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
JPH08337584A
(ja)
|
1995-04-10 |
1996-12-24 |
Dai Ichi Seiyaku Co Ltd |
縮合六環式アミノ化合物、これを含有する医薬及びその製法
|
|
US6504029B1
(en)
|
1995-04-10 |
2003-01-07 |
Daiichi Pharmaceutical Co., Ltd. |
Condensed-hexacyclic compounds and a process therefor
|
|
SG50747A1
(en)
|
1995-08-02 |
1998-07-20 |
Tanabe Seiyaku Co |
Comptothecin derivatives
|
|
CA2192725C
(en)
|
1995-12-28 |
2004-04-20 |
Kenji Tsujihara |
Camptothecin derivatives
|
|
JPH1095802A
(ja)
|
1995-12-28 |
1998-04-14 |
Tanabe Seiyaku Co Ltd |
カンプトテシン誘導体
|
|
US5968511A
(en)
|
1996-03-27 |
1999-10-19 |
Genentech, Inc. |
ErbB3 antibodies
|
|
TW409058B
(en)
|
1996-06-06 |
2000-10-21 |
Daiichi Seiyaku Co |
Method for preparation of a drug complex
|
|
TW527183B
(en)
|
1996-06-06 |
2003-04-11 |
Daiichi Seiyaku Co |
Drug complex
|
|
JPH1171280A
(ja)
|
1997-06-26 |
1999-03-16 |
Tanabe Seiyaku Co Ltd |
医薬組成物
|
|
JPH1192405A
(ja)
|
1997-09-19 |
1999-04-06 |
Dai Ichi Seiyaku Co Ltd |
薬物複合体
|
|
US6071719A
(en)
|
1998-03-11 |
2000-06-06 |
Smithkline Beecham Corporation |
DNA encoding ECR 673: A 7-transmembrane G-protein coupled receptor
|
|
WO1999061061A1
(fr)
|
1998-05-22 |
1999-12-02 |
Daiichi Pharmaceutical Co., Ltd. |
Composites medicamenteux
|
|
MXPA01004239A
(es)
|
1998-10-30 |
2002-06-04 |
Daiichi Seiyaku Co |
Compuesto dds y metodo para la medicion del mismo.
|
|
EP2977063A1
(en)
|
1999-06-25 |
2016-01-27 |
Genentech, Inc. |
Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
|
|
AR024464A1
(es)
|
1999-06-25 |
2002-10-02 |
Genentech Inc |
Anticuerpos anti-erbb2 humanizados.
|
|
JP2002060351A
(ja)
|
2000-03-22 |
2002-02-26 |
Dai Ichi Seiyaku Co Ltd |
水酸基を有する薬物を含むdds化合物
|
|
BR0112287A
(pt)
|
2000-06-29 |
2003-05-06 |
Daiichi Seiyaku Co |
Composto dds e seu método de preparação
|
|
AU2001271037A1
(en)
|
2000-07-13 |
2002-01-30 |
Daiichi Pharmaceutical Co., Ltd. |
Pharmaceutical compositions containing dds compounds
|
|
US20030018989A1
(en)
|
2001-03-29 |
2003-01-23 |
Brennan Thomas J. |
Transgenic mice containing GPCR5-1 gene disruptions
|
|
EP1283053A1
(en)
|
2001-08-09 |
2003-02-12 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Inhibitors of HER3 activity
|
|
TWI313609B
(en)
|
2001-08-21 |
2009-08-21 |
Mitsubishi Tanabe Pharma Corp |
Pharmaceutical composition for inhibiting the metastasis or preventing the recurrence of malignant tumor
|
|
US20050123536A1
(en)
|
2001-11-20 |
2005-06-09 |
Che-Leung Law |
Treatment of immunological disorders using anti-dc30 antibodies
|
|
US8877901B2
(en)
|
2002-12-13 |
2014-11-04 |
Immunomedics, Inc. |
Camptothecin-binding moiety conjugates
|
|
CA2478047C
(en)
|
2002-03-01 |
2014-01-21 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
US9745380B2
(en)
|
2002-03-01 |
2017-08-29 |
Immunomedics, Inc. |
RS7 antibodies
|
|
US20080260744A1
(en)
|
2002-09-09 |
2008-10-23 |
Omeros Corporation |
G protein coupled receptors and uses thereof
|
|
EP1581648A2
(en)
|
2002-09-09 |
2005-10-05 |
Nura, Inc. |
G protein coupled receptors and uses thereof
|
|
CA2508831C
(en)
|
2002-12-13 |
2012-05-01 |
Immunomedics, Inc. |
Immunoconjugates with an intracellularly-cleavable linkage
|
|
EA013225B1
(ru)
|
2003-01-07 |
2010-04-30 |
Симфоген А/С |
Способ получения линии клеток, продуцирующей рекомбинантный поликлональный белок, способ получения поликлонального белка, линия клеток, продуцирующая рекомбинантный поликлональный белок, библиотека векторов, популяция клеток
|
|
US20040202666A1
(en)
|
2003-01-24 |
2004-10-14 |
Immunomedics, Inc. |
Anti-cancer anthracycline drug-antibody conjugates
|
|
WO2005040825A2
(en)
|
2003-10-24 |
2005-05-06 |
Bayer Healthcare Ag |
Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20)
|
|
CA2557547A1
(en)
|
2004-02-26 |
2005-09-09 |
Inotek Pharmaceuticals Corporation |
Isoquinoline derivatives and methods of use thereof
|
|
US7837980B2
(en)
|
2004-03-02 |
2010-11-23 |
Seattle Genetics, Inc. |
Partially loaded antibodies and methods of their conjugation
|
|
BRPI0510909A2
(pt)
|
2004-05-19 |
2008-12-16 |
Medarex Inc |
composto de ligaÇço fÁrmaco-ligante citotàxico, formulaÇço farmacÊutica, mÉtodo para matar uma cÉlula e mÉtodo para retardar ou interromper o crescimento de tumor
|
|
NZ551180A
(en)
|
2004-06-01 |
2009-10-30 |
Genentech Inc |
Antibody drug conjugates and methods
|
|
UA90480C2
(uk)
|
2004-07-22 |
2010-05-11 |
Джэнэнтэк, Инк. |
Фармацевтична композиція, що має протипухлинну активність, яка включає антитіло до her2
|
|
US8802820B2
(en)
|
2004-11-12 |
2014-08-12 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
US20080305044A1
(en)
|
2004-11-29 |
2008-12-11 |
Seattle Genetics, Inc. |
Engineered Antibodies and Immunoconjugates
|
|
EP3698807A1
(en)
|
2005-01-21 |
2020-08-26 |
Genentech, Inc. |
Fixed dosing of her antibodies
|
|
DE102005009099A1
(de)
|
2005-02-28 |
2006-08-31 |
Ktb Tumorforschungsgesellschaft Mbh |
Proteinbindende Camptothecin-Peptid-Derivate und diese enthaltende Arzneimittel
|
|
DE102005009084A1
(de)
|
2005-02-28 |
2006-08-31 |
Ktb Tumorforschungsgesellschaft Mbh |
Proteinbindende Anthrazyklin-Peptid-Derivate und diese enthaltende Arzneimittel
|
|
US7833979B2
(en)
|
2005-04-22 |
2010-11-16 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
AR056857A1
(es)
|
2005-12-30 |
2007-10-24 |
U3 Pharma Ag |
Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
|
|
US20080131428A1
(en)
|
2006-02-24 |
2008-06-05 |
Arius Research, Inc. |
Cytotoxicity mediation of cells evidencing surface expression of TROP-2
|
|
CN101490087B
(zh)
|
2006-05-30 |
2013-11-06 |
健泰科生物技术公司 |
抗体和免疫偶联物及其用途
|
|
PT2032606E
(pt)
|
2006-05-30 |
2014-02-05 |
Genentech Inc |
Anticorpos e imunoconjugados e respetivas utilizações
|
|
ITMI20061473A1
(it)
|
2006-07-26 |
2008-01-27 |
Indena Spa |
Derivati della camptotecina ad attivita antitumorale
|
|
JP2010513524A
(ja)
|
2006-12-21 |
2010-04-30 |
シェーリング コーポレイション |
Kspキネシン活性を阻害するためのピロロ[3,2−a]ピリジン誘導体
|
|
NZ579644A
(en)
|
2007-02-16 |
2012-05-25 |
Merrimack Pharmaceuticals Inc |
Antibodies against erbb3 and uses thereof
|
|
EP2121008A4
(en)
|
2007-03-22 |
2010-03-31 |
Sloan Kettering Inst Cancer |
USE OF MONOCLONAL ANTIBODY 8H9
|
|
CN101687927B
(zh)
|
2007-05-15 |
2013-10-30 |
霍夫曼-拉罗奇有限公司 |
针对g蛋白偶联的受体(gpcr)的抗体
|
|
CN108130327A
(zh)
|
2007-10-11 |
2018-06-08 |
第三共株式会社 |
靶向破骨细胞相关蛋白Siglec-15的抗体
|
|
NZ588884A
(en)
|
2008-04-30 |
2013-05-31 |
Immunogen Inc |
Cross-linkers and their uses
|
|
US8541178B2
(en)
|
2008-05-13 |
2013-09-24 |
Genentech, Inc. |
Analysis of antibody drug conjugates by bead-based affinity capture and mass spectrometry
|
|
CN102282168A
(zh)
|
2008-11-18 |
2011-12-14 |
梅里麦克制药股份有限公司 |
人血清白蛋白接头以及其结合物
|
|
PL3912643T3
(pl)
|
2009-02-13 |
2023-01-23 |
Immunomedics Inc. |
Immunokoniugaty z połączeniem rozszczepialnym wewnątrzkomórkowo
|
|
EP2377932B1
(en)
|
2009-04-09 |
2020-11-18 |
Daiichi Sankyo Company, Limited |
ANTI-Siglec-15 ANTIBODY
|
|
EP2456464A4
(en)
|
2009-07-22 |
2013-02-20 |
Enzon Pharmaceuticals Inc |
METHOD FOR THE TREATMENT OF HER2-POSITIVE CANCER WITH HER2 RECEPTOR ANTAGONISTS IN COMBINATION WITH MULTICARM POLYMER CONJUGATES FROM 7-ETHYL-10-HYDROXYCAMPTOTHECIN
|
|
JP5829520B2
(ja)
|
2009-08-20 |
2015-12-09 |
国立大学法人 千葉大学 |
コルヒチン誘導体
|
|
CA2775350A1
(en)
|
2009-09-24 |
2011-03-31 |
Seattle Genetics, Inc. |
Dr5 ligand drug conjugates
|
|
NZ599100A
(en)
|
2009-10-20 |
2014-07-25 |
Abbvie Inc |
Isolation and purification of anti-il-13 antibodies using protein a affinity chromatography
|
|
KR101806323B1
(ko)
|
2009-11-13 |
2017-12-07 |
다이이치 산쿄 유럽 게엠베하 |
Her-3 관련 질병을 치료하거나 예방하기 위한 물질 및 방법
|
|
IN2012DN03354A
(cg-RX-API-DMAC7.html)
|
2009-12-02 |
2015-10-23 |
Immunomedics Inc |
|
|
ES2661228T3
(es)
|
2010-05-13 |
2018-03-28 |
Indiana University Research And Technology Corporation |
Péptidos de la superfamilia de glucagón que muestran actividad de receptor nuclear de hormona
|
|
EA201500220A1
(ru)
|
2010-05-17 |
2015-10-30 |
Ливтех, Инк. |
Антитело против trop-2 человека, обладающее противоопухолевой активностью in vivo
|
|
CA2927832C
(en)
|
2010-05-18 |
2021-03-23 |
Cerulean Pharma Inc. |
Cyclodextrin-containing polymer-therapeutic agent conjugates and their use
|
|
WO2011155579A1
(ja)
|
2010-06-10 |
2011-12-15 |
北海道公立大学法人札幌医科大学 |
抗Trop-2抗体
|
|
SG186451A1
(en)
|
2010-07-12 |
2013-01-30 |
Covx Technologies Ireland Ltd |
Multifunctional antibody conjugates
|
|
WO2012019024A2
(en)
|
2010-08-04 |
2012-02-09 |
Immunogen, Inc. |
Her3-binding molecules and immunoconjugates thereof
|
|
AU2011286407A1
(en)
|
2010-08-06 |
2013-02-21 |
Amgen |
Use of HER3 binding agents in prostate treatment
|
|
JP6014596B2
(ja)
|
2010-11-09 |
2016-10-25 |
メディミューン,エルエルシー |
均一コンジュゲーションのための抗体足場
|
|
EP2640727B1
(en)
|
2010-11-17 |
2015-05-13 |
Genentech, Inc. |
Alaninyl maytansinol antibody conjugates
|
|
SG11201401699WA
(en)
|
2011-11-11 |
2014-09-26 |
Rinat Neuroscience Corp |
Antibodies specific for trop-2 and their uses
|
|
US9427464B2
(en)
|
2011-11-22 |
2016-08-30 |
Chiome Bioscience Inc. |
Anti-human TROP-2 antibody having an antitumor activity in vivo
|
|
MX2014007121A
(es)
|
2011-12-14 |
2014-09-04 |
Seattle Genetics Inc |
Nuevos conjugados de principio activo-ligante (adc) y su uso.
|
|
US20130280282A1
(en)
|
2012-04-24 |
2013-10-24 |
Daiichi Sankyo Co., Ltd. |
Dr5 ligand drug conjugates
|
|
MX2014015205A
(es)
|
2012-06-14 |
2015-08-14 |
Ambrx Inc |
Anticuerpos anti-psma conjugados a polipeptidos de ligando de receptor nuclear.
|
|
US10195288B2
(en)
|
2012-10-11 |
2019-02-05 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate
|
|
EP2910573B1
(en)
|
2012-10-19 |
2020-02-19 |
Daiichi Sankyo Company, Limited |
Antibody-drug conjugate produced by binding through linker having hydrophilic structure
|
|
MX367748B
(es)
|
2012-12-21 |
2019-09-04 |
Glenmark Pharmaceuticals Sa |
Formulación de anticuerpo anti her2.
|
|
EP2927227A4
(en)
|
2013-01-03 |
2015-12-30 |
Celltrion Inc |
ANTIBODY CONCENTRATOR REMEDY CONJUGATE, METHOD OF MANUFACTURING THEREOF, AND ANTIBODY TOGETHER THEREWITH
|
|
SG10201902571VA
(en)
|
2013-12-25 |
2019-04-29 |
Daiichi Sankyo Co Ltd |
Anti-trop2 antibody-drug conjugate
|
|
SG11201603960XA
(en)
|
2014-01-31 |
2016-07-28 |
Daiichi Sankyo Co Ltd |
Anti-her2 antibody-drug conjugate
|
|
CN122399016A
(zh)
|
2014-03-15 |
2026-07-17 |
诺华股份有限公司 |
使用嵌合抗原受体治疗癌症
|
|
JP2017114763A
(ja)
|
2014-03-26 |
2017-06-29 |
第一三共株式会社 |
抗cd98抗体−薬物コンジュゲート
|
|
TWI871999B
(zh)
|
2014-04-10 |
2025-02-01 |
日商第一三共股份有限公司 |
抗her3抗體-藥物結合物
|
|
US11185594B2
(en)
|
2014-04-10 |
2021-11-30 |
Daiichi Sankyo Company, Limited |
(Anti-HER2 antibody)-drug conjugate
|
|
MX2017001946A
(es)
|
2014-08-12 |
2017-06-19 |
Novartis Ag |
Conjugados de farmacos con anticuerpos anti-cdh6.
|
|
WO2016131409A1
(zh)
|
2015-02-17 |
2016-08-25 |
上海美雅珂生物技术有限责任公司 |
抗体药物偶联物
|
|
CA2990572C
(en)
|
2015-06-29 |
2022-07-26 |
Daiichi Sankyo Company, Limited |
Method for selectively manufacturing antibody-drug conjugate
|
|
CN108700598A
(zh)
*
|
2016-03-25 |
2018-10-23 |
豪夫迈·罗氏有限公司 |
多路总抗体和抗体缀合的药物量化测定法
|
|
WO2018066626A1
(ja)
|
2016-10-07 |
2018-04-12 |
第一三共株式会社 |
抗her2抗体-薬物コンジュゲート投与による耐性癌の治療
|
|
SG11201906554RA
(en)
|
2017-01-17 |
2019-08-27 |
Daiichi Sankyo Co Ltd |
Anti-gpr20 antibody and anti-gpr20 antibody-drug conjugate
|
|
WO2018185618A1
(en)
|
2017-04-03 |
2018-10-11 |
Novartis Ag |
Anti-cdh6 antibody drug conjugates and anti-gitr antibody combinations and methods of treatment
|
|
TWI926682B
(zh)
|
2017-05-15 |
2026-05-21 |
日商第一三共股份有限公司 |
抗體-藥物結合物之製造方法
|